[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342239-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342239-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","tumor-microenvironment-responsive-nanoformulations-for-breast-cancer","Tumor microenvironment–responsive nanoformulations for breast cancer","","Nanomedicine enables regulated, targeted drug delivery and has shown positive outcomes in breast cancer treatment. Stimulus-responsive nanodrug delivery systems are increasingly used to control drug release according to the interior cancer microenvironment, improving therapeutic performance. This review synthesizes internal stimulus-responsive nanoparticle platforms targeting pH, redox, enzymes, reactive oxygen species, and hypoxia, and discusses future perspectives for the field. Stimulus-responsive nanoparticles can stay stable in physiological conditions while releasing drugs upon specific activation, prolonging circulation and increasing tumor uptake for enhanced biosafety.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tumor-microenvironment-responsive-nanoformulations-for-breast-cancer/342239/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tumor-microenvironment-responsive-nanoformulations-for-breast-cancer/342239.png","ImageObject",300,407,{"name":42,"@type":43},"Genevieve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem do stimulus-responsive nanodrug delivery systems address in breast cancer therapy?","Question",{"text":63,"@type":64},"They manage drug release based on the interior environment of the cancer, helping nanoparticles activate in response to specific stimuli rather than releasing indiscriminately.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which internal stimuli are covered for tumor microenvironment–responsive nanoparticles in this review?",{"text":68,"@type":64},"The review summarizes pH, redox, enzyme, reactive oxygen species, and hypoxia responsive nanoparticle drug delivery systems.",{"name":70,"@type":61,"acceptedAnswer":71},"Why are stimulus-responsive nanoparticles described as beneficial for therapeutic performance and biosafety?",{"text":72,"@type":64},"They can remain stable under physiological conditions, then rapidly release drugs when activated by tumor-specific stimuli, which prolongs circulation and increases cancer cellular uptake while improving biosafety.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342239,1790071069,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Review  \nTumor microenvironment–responsive nanoformulations for breast cancer  \nPallavi Velapure1 · Divyanshi kansal1 · Chandrashekhar Bobade1  \nReceived: 9 September 2024 / Accepted: 7 October 2024  \n© The Author(s) 2024 OPEN  \nAbstract  \nNanomedicine, the most promising approach for regulated and targeted drug delivery, is frequently applied in cancer treatment. Essentially, accumulating evidence indicates that nanomedicine has positive results in the treatment of breast cancer (BC), with many BC patients benefiting from nanomedicine-related treatments. Currently, nanodrug delivery systems based on stimulus responses are gaining popularity because of their additional ability to manage drug release depending on the interior environment of the cancer. This review includes a synopsis of several types of internal (pH, redox, enzyme, reactive oxygen species, and hypoxia) stimuli-responsive nanoparticle drug delivery systems as well as perspectives for forthcoming times. Stimulus-responsive nanoparticles can remain stable under physiological conditions while being rapidly activated to release drugs in response to specific stimuli, prolonging blood circulation and increasing cancer cellular uptake, resulting in excellent therapeutic performance and improved biosafety. In this paper, we discuss tumor microenvironment responsive Nanoformulation for breast cancer treatment.  \nKeywords Tumor microenvironment · Stimuli responsive · Breast cancer · Nanomedicine · Drug delivery systems  \n1 Introduction  \nCancer is the main cause of human fatalities. In the fight against cancer, the general approaches employed in chemotherapy face certain limitations, including the occurrence of adverse effects caused by the accumulation of drugs in healthy cells rather than in cancerous cells [1, 2] . Progress in nanomedicine, with significant implications for treating cancer, has opened novel avenues for targeted therapy. The enhanced permeability and retention (EPR) result serves asa vital procedure for nanoparticles aimed at cancer sites [3]. The shape and surface characteristics of nanoparticles affect their capacity to cluster at tumor sites through the EPR effect [4] .  \nNanoparticles that respond to stimuli can transport therapeutic drug molecules to tumors without harming the surrounding tissue [5]. With advancements in nanotechnology, nanomedicine, and material chemistry, the utilization of these responsive particles in cancer chemotherapy has been increasingly recognized [6] .  \nBreast cancer ranks as the most common tumor among women or stands as the second-highest contributor to cancerrelated disorder mortality amongst women [7] . Breast cancer care has evolved significantly in recent years because of a number of breakthroughs aimed at improving early detection, diagnosis, therapy, and survival rates [8] . Rapid progress has been made in breast imaging techniques and localization methods, personalized medicine through genetic and  \n* Chandrashekhar Bobade, [chandrashekhar.bobade@mitwpu.edu.in](chandrashekhar.bobade@mitwpu.edu.in); Pallavi Velapure, [pallavi.velapure@mitwpu.edu.in |](pallavi.velapure@mitwpu.edu.in |1School)[1](pallavi.velapure@mitwpu.edu.in |1School)[School](pallavi.velapure@mitwpu.edu.in |1School)[ ](pallavi.velapure@mitwpu.edu.in |1School)[of Health Science and Technology](of Health Science and Technology), Dr. Vishwanath Karad MIT World Peace University, S.No. 124, MIT Campus, Paud Road, Kothrud, Pune 411038, Maharashtra, India.  \nDiscover Nano  \n(2024) 19:212  \n| [https://doi.org/10.1186/s11671-024-04122-5](https://doi.org/10.1186/s11671-024-04122-5)  \ngenomic profiling, and the development of implantable devices [9]. Additionally, the integration of artificial intelligence and deep learning models has revolutionized tasks such as image analysis, image-guided surgery, surgical planning, and predicting treatment outcomes [10] .  \n1.1 Breast cancer  \nA breast’s structure comprises three primary elements: lobes, ducts, or conn","cbCailWAPOB7EVvg","https://ap.wps.com/l/cbCailWAPOB7EVvg","pdf",1198260,17,"English","# 1 Introduction\n## 1.1 Breast cancer","[{\"question\":\"What problem do stimulus-responsive nanodrug delivery systems address in breast cancer therapy?\",\"answer\":\"They manage drug release based on the interior environment of the cancer, helping nanoparticles activate in response to specific stimuli rather than releasing indiscriminately.\"},{\"question\":\"Which internal stimuli are covered for tumor microenvironment–responsive nanoparticles in this review?\",\"answer\":\"The review summarizes pH, redox, enzyme, reactive oxygen species, and hypoxia responsive nanoparticle drug delivery systems.\"},{\"question\":\"Why are stimulus-responsive nanoparticles described as beneficial for therapeutic performance and biosafety?\",\"answer\":\"They can remain stable under physiological conditions, then rapidly release drugs when activated by tumor-specific stimuli, which prolongs circulation and increases cancer cellular uptake while improving biosafety.\"}]","Tumor microenvironment–responsive nanoformulations for breast cancer | PDF",1790045874,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52e29a1694682c4cc8753d91c4ca42e6.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8464723a974ebca2721da591e4d3ee0.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/944cb860732ad63ff44e2343a7fdff75.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5b7eeba8adfb61e1a418213d6131d95.webp",980,1301]